BACKGROUND: Severe combined immunodeficiency (SCID) is characterized by arrested T-lymphocyte production and by B-lymphocyte dysfunction, which result in life-threatening infections. Early diagnosis of SCID through population-based screening of newborns can aid clinical management and help improve outcomes; it also permits the identification of previously unknown factors that are essential for lymphocyte development in humans. METHODS: SCID was detected in a newborn before the onset of infections by means of screening of T-cell-receptor excision circles, a biomarker for thymic output. On confirmation of the condition, the affected infant was treated with allogeneic hematopoietic stem-cell transplantation. Exome sequencing in the patient and parents was followed by functional analysis of a prioritized candidate gene with the use of human hematopoietic stem cells and zebrafish embryos. RESULTS: The infant had "leaky" SCID (i.e., a form of SCID in which a minimal degree of immune function is preserved), as well as craniofacial and dermal abnormalities and the absence of a corpus callosum; his immune deficit was fully corrected by hematopoietic stem-cell transplantation. Exome sequencing revealed a heterozygous de novo missense mutation, p.N441K, in BCL11B. The resulting BCL11B protein had dominant negative activity, which abrogated the ability of wild-type BCL11B to bind DNA, thereby arresting development of the T-cell lineage and disrupting hematopoietic stem-cell migration; this revealed a previously unknown function of BCL11B. The patient's abnormalities, when recapitulated in bcl11ba-deficient zebrafish, were reversed by ectopic expression of functionally intact human BCL11B but not mutant human BCL11B. CONCLUSIONS: Newborn screening facilitated the identification and treatment of a previously unknown cause of human SCID. Coupling exome sequencing with an evaluation of candidate genes in human hematopoietic stem cells and in zebrafish revealed that a constitutional BCL11B mutation caused human multisystem anomalies with SCID and also revealed a prethymic role for BCL11B in hematopoietic progenitors. (Funded by the National Institutes of Health and others.).
BACKGROUND: Severe combined immunodeficiency (SCID) is characterized by arrested T-lymphocyte production and by B-lymphocyte dysfunction, which result in life-threatening infections. Early diagnosis of SCID through population-based screening of newborns can aid clinical management and help improve outcomes; it also permits the identification of previously unknown factors that are essential for lymphocyte development in humans. METHODS:SCID was detected in a newborn before the onset of infections by means of screening of T-cell-receptor excision circles, a biomarker for thymic output. On confirmation of the condition, the affected infant was treated with allogeneic hematopoietic stem-cell transplantation. Exome sequencing in the patient and parents was followed by functional analysis of a prioritized candidate gene with the use of human hematopoietic stem cells and zebrafish embryos. RESULTS: The infant had "leaky" SCID (i.e., a form of SCID in which a minimal degree of immune function is preserved), as well as craniofacial and dermal abnormalities and the absence of a corpus callosum; his immune deficit was fully corrected by hematopoietic stem-cell transplantation. Exome sequencing revealed a heterozygous de novo missense mutation, p.N441K, in BCL11B. The resulting BCL11B protein had dominant negative activity, which abrogated the ability of wild-type BCL11B to bind DNA, thereby arresting development of the T-cell lineage and disrupting hematopoietic stem-cell migration; this revealed a previously unknown function of BCL11B. The patient's abnormalities, when recapitulated in bcl11ba-deficient zebrafish, were reversed by ectopic expression of functionally intact humanBCL11B but not mutant humanBCL11B. CONCLUSIONS: Newborn screening facilitated the identification and treatment of a previously unknown cause of humanSCID. Coupling exome sequencing with an evaluation of candidate genes in human hematopoietic stem cells and in zebrafish revealed that a constitutional BCL11B mutation caused humanmultisystem anomalies with SCID and also revealed a prethymic role for BCL11B in hematopoietic progenitors. (Funded by the National Institutes of Health and others.).
Authors: James W Verbsky; Mei W Baker; William J Grossman; Mary Hintermeyer; Trivikram Dasu; Benedetta Bonacci; Sreelatha Reddy; David Margolis; James Casper; Miranda Gries; Ken Desantes; Gary L Hoffman; Charles D Brokopp; Christine M Seroogy; John M Routes Journal: J Clin Immunol Date: 2011-11-10 Impact factor: 8.317
Authors: Alejandro Gutierrez; Alex Kentsis; Takaomi Sanda; Linda Holmfeldt; Shann-Ching Chen; Jianhua Zhang; Alexei Protopopov; Lynda Chin; Suzanne E Dahlberg; Donna S Neuberg; Lewis B Silverman; Stuart S Winter; Stephen P Hunger; Stephen E Sallan; Shan Zha; Frederick W Alt; James R Downing; Charles G Mullighan; A Thomas Look Journal: Blood Date: 2011-08-30 Impact factor: 22.113
Authors: William T Shearer; Elizabeth Dunn; Luigi D Notarangelo; Christopher C Dvorak; Jennifer M Puck; Brent R Logan; Linda M Griffith; Donald B Kohn; Richard J O'Reilly; Thomas A Fleisher; Sung-Yun Pai; Caridad A Martinez; Rebecca H Buckley; Morton J Cowan Journal: J Allergy Clin Immunol Date: 2013-11-28 Impact factor: 10.793
Authors: Jay P Patel; Jennifer M Puck; Rajgopal Srinivasan; Christina Brown; Uma Sunderam; Kunal Kundu; Steven E Brenner; Richard A Gatti; Joseph A Church Journal: J Clin Immunol Date: 2015-02-13 Impact factor: 8.317
Authors: Christopher C Dvorak; Elie Haddad; Rebecca H Buckley; Morton J Cowan; Brent Logan; Linda M Griffith; Donald B Kohn; Sung-Yun Pai; Luigi Notarangelo; William Shearer; Susan Prockop; Neena Kapoor; Jennifer Heimall; Sonali Chaudhury; David Shyr; Sharat Chandra; Geoff Cuvelier; Theodore Moore; Shalini Shenoy; Fred Goldman; Angela R Smith; Gauri Sunkersett; Mark Vander Lugt; Emi Caywood; Troy Quigg; Troy Torgerson; Shanmuganathan Chandrakasan; John Craddock; Blachy J Dávila Saldaña; Alfred Gillio; Evan Shereck; Victor Aquino; Kenneth DeSantes; Alan Knutsen; Monica Thakar; Lolie Yu; Jennifer M Puck Journal: J Allergy Clin Immunol Date: 2018-09-05 Impact factor: 10.793
Authors: Passorn Winkler; Martin Delin; Piotr Grabarczyk; Praveen K Sappa; Sander Bekeschus; Petra Hildebrandt; Grzegorz K Przybylski; Uwe Völker; Elke Hammer; Christian A Schmidt Journal: Mol Cell Biol Date: 2018-02-12 Impact factor: 4.272
Authors: Davor Lessel; Christina Gehbauer; Nuria C Bramswig; Caroline Schluth-Bolard; Sathish Venkataramanappa; Koen L I van Gassen; Maja Hempel; Tobias B Haack; Anja Baresic; Casie A Genetti; Mariana F A Funari; Ivana Lessel; Leonie Kuhlmann; Ruth Simon; Pentao Liu; Jonas Denecke; Alma Kuechler; Ineke de Kruijff; Moneef Shoukier; Monkol Lek; Thomas Mullen; Hermann-Josef Lüdecke; Antonio M Lerario; Robin Kobbe; Thorsten Krieger; Benedicte Demeer; Marine Lebrun; Boris Keren; Caroline Nava; Julien Buratti; Alexandra Afenjar; Marwan Shinawi; Maria J Guillen Sacoto; Julie Gauthier; Fadi F Hamdan; Anne-Marie Laberge; Philippe M Campeau; Raymond J Louie; Sara S Cathey; Immo Prinz; Alexander A L Jorge; Paulien A Terhal; Boris Lenhard; Dagmar Wieczorek; Tim M Strom; Pankaj B Agrawal; Stefan Britsch; Eva Tolosa; Christian Kubisch Journal: Brain Date: 2018-08-01 Impact factor: 13.501
Authors: George S Amatuni; Robert J Currier; Joseph A Church; Tracey Bishop; Elena Grimbacher; Alan Anh-Chuong Nguyen; Rajni Agarwal-Hashmi; Constantino P Aznar; Manish J Butte; Morton J Cowan; Morna J Dorsey; Christopher C Dvorak; Neena Kapoor; Donald B Kohn; M Louise Markert; Theodore B Moore; Stanley J Naides; Stanley Sciortino; Lisa Feuchtbaum; Rasoul A Koupaei; Jennifer M Puck Journal: Pediatrics Date: 2019-02 Impact factor: 7.124